Related Experiment Video
Updated: Feb 28, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic
Angela Gutierrez-Camino1, Natanja Oosterom, Marissa A H den Hoed
1aDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursery bBioCruces Health Research Institute, University of the Basque Country (UPV/EHU), Leioa, Spain cPrincess Máxima Center for Pediatric Oncology, Utrecht dDepartment of Clinical Chemistry, Erasmus Medical Center eDepartment of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia's Children's Hospital, Rotterdam fDepartment of Clinical Chemistry, VU Medical Center, Amsterdam gDepartment of Pediatric Oncology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands hDepartment of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract:
Five-year survival rates of pediatric acute lymphoblastic leukemia (ALL) have reached 90% in the developed countries. However, toxicity because of methotrexate (MTX) occurs frequently. Variety in the occurrence of toxicity is partly determined by single nucleotide polymorphisms (SNPs) in coding regions. Recently, five SNPs in non-coding pre-microRNAs and microRNA processing (miRNA) genes were identified in association with MTX-induced oral mucositis. This study aimed to replicate the association of these miRNA variants in relation to MTX-induced oral mucositis in a prospective childhood ALL cohort. Three out of five SNPs with a minor allele frequency more than 0.15 [CCR4-NOT transcription complex (CNOT4) rs3812265, miR-1206 rs2114358, miR-2053 rs10505168] were analyzed in 117 pediatric ALL patients treated with 5 g/m MTX (DCOG ALL-10). Oral mucositis was defined as grade more than or equal to 3 according to the National Cancer Institute criteria. rs2114358 in miR-1206 was associated with oral mucositis [odds ratio (OR): 3.6; 95% confidence interval (CI): 1.1-11.5], whereas we did not confirm the association of CNOT4 rs3812265 (OR: 0.69; 95% CI: 0.27-1.80) and miR-2053 rs10505168 (OR: 2.50; 95% CI: 0.76-8.24). Our results replicate the association between rs2114358 in miR-1206 and MTX-induced oral mucositis in childhood ALL. Genetic variation in miR-1206 has potential as a novel biomarker to predict MTX-induced toxicity.
Insights
Genetic variations in microRNA genes can predict methotrexate toxicity in children with acute lymphoblastic leukemia (ALL). Specifically, a variant in miR-1206 is linked to oral mucositis, offering a potential biomarker for personalized treatment strategies.
Area of Science:
- Pharmacogenomics
- Oncology
- Molecular Biology
Background:
- Pediatric acute lymphoblastic leukemia (ALL) survival rates are high (90%) in developed nations.
- Methotrexate (MTX) chemotherapy frequently causes toxicity, including oral mucositis.
- Genetic variations, particularly single nucleotide polymorphisms (SNPs) in microRNA (miRNA) genes, may influence MTX toxicity.
Purpose of the Study:
- To replicate the association between specific miRNA variants and MTX-induced oral mucositis in a prospective pediatric ALL cohort.
- To identify potential genetic biomarkers for predicting MTX toxicity in children undergoing ALL treatment.
Main Methods:
- Genotyping of three SNPs (CNOT4 rs3812265, miR-1206 rs2114358, miR-2053 rs10505168) in 117 pediatric ALL patients.
- Patients received 5 g/m² MTX as part of the DCOG ALL-10 protocol.
- Oral mucositis was assessed using National Cancer Institute criteria (grade ≥3).
Main Results:
- The SNP rs2114358 in miR-1206 was significantly associated with oral mucositis (Odds Ratio: 3.6; 95% Confidence Interval: 1.1-11.5).
- No significant association was found for CNOT4 rs3812265 (OR: 0.69; 95% CI: 0.27-1.80) or miR-2053 rs10505168 (OR: 2.50; 95% CI: 0.76-8.24).
- The findings replicate the link between miR-1206 genetic variation and MTX-induced oral mucositis.
Conclusions:
- Genetic variation in miR-1206, specifically rs2114358, is confirmed as a predictor of MTX-induced oral mucositis in childhood ALL.
- miR-1206 variants represent a promising novel biomarker for predicting MTX toxicity.
- This finding supports the potential for personalized medicine approaches in pediatric ALL treatment to mitigate MTX-related side effects.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
MicroRNAs
MicroRNAs